CA Patent

CA2832953A1 — Compositions and methods for the treatment of nasal conditions

Assigned to Eye Therapies LLC · Expires 2012-10-18 · 14y expired

What this patent protects

The invention provides compositions and methods for treating nasal congestion. The provided compositions and methods utilize iow concentrations of selective a-2 adrenergic receptor agonists. The compositions preferably include brimonidine.

USPTO Abstract

The invention provides compositions and methods for treating nasal congestion. The provided compositions and methods utilize iow concentrations of selective a-2 adrenergic receptor agonists. The compositions preferably include brimonidine.

Drugs covered by this patent

Patent Metadata

Patent number
CA2832953A1
Jurisdiction
CA
Classification
—
Expires
2012-10-18
Drug substance claim
No
Drug product claim
No
Assignee
Eye Therapies LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.